US FDA To Lose Another COVID-19 Response Leader With Anand Shah’s Resignation

Shah, deputy commissioner for medical and scientific affairs, has been overseeing FDA’s COVID-19 Pandemic Recovery and Preparedness Plan. His departure the week of 20 January follows that of FDA Chief Counsel Amy Amin, whose resignation led to dueling appointments to temporarily fill her post.

Career crossroads
FDA Deputy Director for Medical and Scientific Affairs Anand Shah is moving on from government post • Source: Shutterstock

Anand Shah, the US Food and Drug Administration’s deputy commissioner for medical and scientific affairs, is leaving the agency after a second stint to pursue a new career path outside government. One of FDA's top-ranking officials, he has been overseeing the agency’s COVID-19 Pandemic Recovery and Preparedness Plan.

Shah said in an interview that he had tendered his resignation on 11 January and would be leaving next week,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership